Zonisamide and Diovan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zonisamide (zonisamide) and Diovan (valsartan). Common drug interactions include bone disorder among females and alanine aminotransferase increased among males.

The phase IV clinical study analyzes what interactions people have when they take Zonisamide and Diovan. It is created by eHealthMe based on reports of 65 people who take the same drugs from the FDA, and is updated regularly.

What is Zonisamide?

Zonisamide has active ingredients of zonisamide. It is often used in epilepsy. eHealthMe is studying from 11,445 Zonisamide users. Check the latest studies of Zonisamide.

What is Diovan?

Diovan has active ingredients of valsartan. It is often used in high blood pressure. eHealthMe is studying from 83,154 Diovan users. Check the latest studies of Diovan.



On Aug, 09, 2026

65 people who take Zonisamide and Diovan together, and have interactions are studied.

Zonisamide and Diovan drug interactions.

What are the common drug interactions of Zonisamide and Diovan, by gender? *:

female:

  1. Bone disorder
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Chronic kidney disease
  4. Confusional state
  5. Death
  6. Drug hypersensitivity
  7. Drug ineffective
  8. Dysgeusia (disorder of the sense of taste)
  9. Dysphagia (a condition in which swallowing is difficult or painful)
  10. Gastric mucosal lesion (lesion of stomach mucous membrane)

male:

  1. Alanine aminotransferase increased
  2. Blood lactate dehydrogenase increased
  3. Vascular insufficiency
  4. Drug eruption (adverse drug reaction of the skin)
  5. Pyrexia (fever)
  6. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  7. Accident
  8. Dysphagia (a condition in which swallowing is difficult or painful)
  9. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  10. Hypercalcaemia (elevated calcium (ca+) level in the blood)

What are the common drug interactions of Zonisamide and Diovan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  2. Inappropriate antidiuretic hormone secretion

50-59:

  1. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  2. White blood cell count increased
  3. Alopecia (absence of hair from areas of the body)
  4. Cerebral haemorrhage (bleeding within the brain)
  5. Hot flush (sudden feelings of heat)
  6. Mycoplasma infection (bacterial infection)
  7. Staphylococcal infection (an infection with staphylococcus bacteria)
  8. Stress
  9. Varicella
  10. Alanine aminotransferase increased

60+:

  1. Neuropathy peripheral (surface nerve damage)
  2. Cerebellar atrophy (degeneration of the section of the brain responsible for balance, voluntary muscle movements)
  3. Muscular weakness (muscle weakness)
  4. Aphasia (damage to the parts of the brain that control language)
  5. Hypoglycaemia (deficiency of glucose in the bloodstream)
  6. Urinary tract infection
  7. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  8. Frostbite (damage is caused to skin and other tissues due to freezing)
  9. Haemorrhage (bleeding)
  10. Laceration (tearing of soft body tissue)

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 11 people, 16.92%
  2. Cerebral Haemorrhage (bleeding within the brain): 11 people, 16.92%
  3. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 6 people, 9.23%
  4. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 6 people, 9.23%
  5. Diabetes: 6 people, 9.23%
  6. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 9.23%
  7. Agitation (state of anxiety or nervous excitement): 6 people, 9.23%
  8. Hyperlipidaemia (presence of excess lipids in the blood): 5 people, 7.69%
  9. Depression: 5 people, 7.69%
  10. Cerebral Infarction (less blood supply to brain resulting tissue damage): 5 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Zonisamide and Diovan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Zonisamide and Diovan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zonisamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Diovan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zonisamide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Diovan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on zonisamide and valsartan (the active ingredients of Zonisamide and Diovan, respectively), and Zonisamide and Diovan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: